Unilever shares gain after first quarter underlying sales beat expectations
Unilever continues to expect full-year underlying sales growth in the lower half of its multi-year 3% - 5% range
Company
Unilever PLC
LON:ULVR
Unilever is a global supplier of consumer goods, the company`s brands include Knorr, Lipton, Hellmann’s, Magnum, Omo, Dove, Lux and Axe/Lynx.
400 stories · page 11 of 20
Archive
FTSE 100 closes lower ahead of the Easter weekend
The UK's premier stock index finished down around 11 points at 7,459
Archive
Unilever and retail sales in focus ahead of the Easter weekend
Its an early finish for the market this week, but, there's a little bit more news to come.
Investments and investor services
FTSE 100 closes flat as traders don't know which way to turn
Footsie closed down around 0.19 at 7,436, while mid-cap FTSE 250 was up around 95 points at 19,807
Archive
Hot cross buns will be wanted but there is still plenty to digest in the week before Easter
There will be plethora of UK data - jobs, inflation, and retail sales - plus corporate updates from the likes of Unilever, BHP Rio Tinto, Bunzl and Rentokil Initial
Archive
Could other firms potentially bar British shareholders over a hard Brexit?
In February, IAG said it would put a cap on its number on non-EU investors, a move that was replicated on Tuesday by Ryanair, although the Irish carrier went further saying that in the event of a no-deal Brexit it would class UK-held shares
Verde AgriTech taps Felipe Buscacio Paolucci as new CFO
For 2019, the Brazil-focused agricultural fertilizer company plans to sell 200,000 tonnes of crop protection and nutrition products
Archive
FTSE 100 closes a tad higher but sentiment dented by US data
FTSE 100 closed up just over six points at 7,197, while FTSE 250 shed over 74 at 18,898
Archive
Drug firms AstraZeneca and Indivior to be in spotlight on Thursday
AstraZeneca, Indivior and Coca-Cola HBC are among the higher profile names in the schedule for Thursday.
Archive
Big Pharma is big news for Wednesday as GSK reports results for 2018
The launch of a generic rival to its Advair inhaler has many expecting a downgrade to Glaxo's outlook
Archive
Bank of England's 'Super Thursday' and slew of corporate earnings eyed as Chinese New Year begins
The week ahead includes updates from Thomas Cook, Superdry, Ryanair and Tate & Lyle, among others.
Unilever shares fall as final quarter sales miss expectations
Unilever expects underlying sales growth in 2019 to be at the lower end of its forecast range
Investments and investor services
FTSE 100 closes higher, bolstered by resource stocks
The premier index of leading shares added around 27 points to finish at 6,968
Archive
First big wave of corporate results to hit on Thursday: BT, Unilever, Shell, Diageo to stand out
Aside from the tide of blue-chip results, some big second line news will also flow on Thursday from the likes of Britvic, Dairy Crest, Premier Oil, Rank Group, and Renishaw
Investments and investor services
FTSE 100 closes lower as trade worries dent global equities; Ocado top Footsie gainer
A deceptively dull start by the Footsie gradually turned into something a bit more dramatic
Unilever's U-turn on HQ relocation 'unhelpful' to shares, says UBS
UBS cut its recommendation on Unilever's stock to ‘neutral’ from ‘buy’ and left its target price at 4,400p
How RBS’s management team can achieve a FTSE 100 first in 2019
Never in the FTSE 100's 34-year history has a blue-chip company had women filling the top two executive roles
Forget the Turkey: Unilever purchases fast-growing Dutch plant-based meat replacements producer, The Vegetarian Butcher: report
Reuters said that the takeover will see the Anglo-Dutch consumer products giant acquire the maker of vegetarian hamburgers, imitation meatballs and fishless tuna for an undisclosed sum
Lloyds, Vodafone, BP, GSK and Sirius Minerals the top traded companies of 2018
The Share Centre's Helal Miah said Lloyds' dividends have been restored to historic norms as profits have recovered after its restructuring
Barclays downgrades GSK; warns of “significant EPS dilution” from Tesaro acquisition
Barclays reckons the GSK valuation remains appealing, but is waiting until 2019 before piling back in, as it thinks the shares might drift a little lower yet